Приказ основних података о документу

dc.creatorTomić, Jovana
dc.creatorĐajić, Nevena
dc.creatorAgbaba, Danica
dc.creatorOtašević, Biljana
dc.creatorMalenović, Anđelija
dc.creatorProtić, Ana
dc.date.accessioned2022-12-07T15:08:24Z
dc.date.available2022-12-07T15:08:24Z
dc.date.issued2022
dc.identifier.issn1233-2356
dc.identifier.urihttps://farfar.pharmacy.bg.ac.rs/handle/123456789/4331
dc.description.abstractThis paper is aimed at developing a gradient elution reversed-phase high-performance liquid chromatography (RP-HPLC) method for the separation of a complex mixture composed of ivabradine and its eleven impurities, in a reasonable timeframe. In order to obtain a robust and reliable HPLC method for separation of this mixture, Analytical Quality by Design (AQbD) was applied. This approach demonstrated to be useful in development of a long lasting life cycle methods. Four chromatographic variables were defined as key method parameters (KMPs) and optimized towards the analytical target profile (ATP). Designated KMPs were initial and final amount of acetonitrile in the mobile phase, pH value of the aqueous phase and gradient time, while resolutions of critical peak pairs were denoted as critical method attributes (CMAs). Relationships between KMPs and CMAs were obtained with the aid of Design of Experiments (DoEs) methodology among which Box-Behnken design (BBD) was employed to gain valid mathematical models. Obtained mathematical equations were used to construct the Design Space (DS) and select reliable optimal separation conditions. They included 11% (v/v) and 34% (v/v) of initial and final amount of acetonitrile, respectively, as well as 45 min of gradient elution time and 20 mM ammonium acetate as aqueous mobile phase with pH set to 7.35. The possibility to separate the diastereoisomers of impurity X was also evaluated. It was demonstrated that this separation could not be achieved in gradient elution mode within the defined variable domains and in a reasonable time span. The developed method was validated according to ICH Q2 (R1) guideline and met all the required criteria.
dc.publisherAkademiai Kiado ZRt.
dc.relationinfo:eu-repo/grantAgreement/MESTD/inst-2020/200161/RS//
dc.rightsopenAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.sourceActa Chromatographica
dc.subjectAnalytical Quality by Design
dc.subjectBox-Behnken design
dc.subjectgradient elution RP-HPLC method
dc.subjectivabradine
dc.titleRobust optimization of gradient RP HPLC method for simultaneous determination of ivabradine and its eleven related substances by AQbD approach
dc.typearticle
dc.rights.licenseBY-NC
dc.citation.volume34
dc.citation.issue1
dc.citation.spage1
dc.citation.epage11
dc.citation.rankM23
dc.identifier.wos000692391100001
dc.identifier.doi10.1556/1326.2021.00885
dc.identifier.scopus2-s2.0-85118212359
dc.identifier.fulltexthttp://farfar.pharmacy.bg.ac.rs/bitstream/id/11136/Robust_optimization_of_pub_2022.pdf
dc.type.versionpublishedVersion


Документи

Thumbnail

Овај документ се појављује у следећим колекцијама

Приказ основних података о документу